24/04/2014 07:40:01 Cookie Policy Free Membership Login

NYSE Market News

Boeing Making Headlines Including This One

23 Apr 2014 @ 23:00
Boeing’s share price (NYSE:BA) is up 2% today to 130.10, the highest that it has been since 03 March. Since falling below the 130.00 mark on 29 January, it has broken the barrier only three times before today. Boeing stock closed yesterday at 127.55, opening this morning at 130.75, following a spate of major announcements over the past several days. Revenues u↑p, Earnings do↓wn. First...

NYSE to Suspend Trading Immediately in Genco Shipping & Trading

22 Apr 2014 @ 21:48
Commencing delisting proceedings The New York Stock Exchange announced today that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the common stock of Genco Shipping & Trading Limited – (NYSE:GNK) – from the NYSE. Trading in the Company’s common stock will be suspended immediately. NYSE Regulation has determined that the Company is no...

Footsie Pharmaceutical Day

22 Apr 2014 @ 14:19
The usual, quiet, long Easter weekend has passed and the markets have opened to a roar from the pharmaceutical sector that one would expect to accompany the announcement of a new drug that both cures cancer and encourages erections that last more than four hours. Let’s identify the companies first, then try to sort it all out. In no particular order, the market is in a buzz because of...

Fermentalg lists on Euronext Paris

21 Apr 2014 @ 21:44
EnterNext, the Euronext subsidiary designed to promote and grow its market for SMEs, has congratulated Fermentalg, an industrial biotechnology company producing oils and proteins from microalgae, on its listing on Euronext’s regulated market in Paris (compartment C). Founded in 2009 par Pierre Calleja, Fermentalg is an industrial biotechnology company that specialises in producing sustainable...

We Call It "The ADVFN Effect"

21 Apr 2014 @ 14:50
On Thursday, 17 April, we ran a story about General Mills (NYSE:GIS), the tenth largest food manufacturer in the world. That story gave wide public exposure to the company’s new policy that, by a person indicating he ”likes” their products (via social media or coupon usage, for instance), he may not file suit against General Mills for product issues. Those consumers who were...

Could General Mills Change the Rules?

17 Apr 2014 @ 17:25
General Mills (NYSE:GIS) is one of the world’s ten largest food companies. Fast Company recently said, “Pressure from consumers and shareholders is causing many of the biggest food and beverage companies in the world to improve their social and environmental policies.” On April 2nd, General Mills took a major step toward addressing some of those policies, especially as...

GlaxoSmithKline In Trouble Again!

14 Apr 2014 @ 15:27
Already in trouble in China and Iraq, GlaxoSmithKline (LSE:GSK) is now under investigation in Poland on allegations of bribery. Although the GSK share price has been losing ground today in early trading and following the opening of the exchange, it remains to be seen how shares will perform on the New York Exchange (NYSE:GSK). The GSK share price on the London Exchange is at 1,542, down 0.9...

Orchid Island Capital announces closing of sale of shares

13 Apr 2014 @ 12:27
Pursuant to full exercise of underwriters’ overallotment option Orchid Island Capital, (NYSE:ORC) announced today the closing of the sale of 480,000 shares of its common stock for net proceeds of $5,696,640 pursuant to the full exercise of the underwriters’ overallotment option granted in connection with the Company’s public offering that closed on March 24, 2014. All of the...

Red Lion sells Yakima Hotel

13 Apr 2014 @ 12:23
New owner of Red Lion Hotel Yakima to make significant improvements Red Lion Hotels Corporation (NYSE:RLH) today announced the company has sold the Red Lion Hotel Yakima in Washington. At closing, the company entered into an agreement with the new owner to retain the hotel as a franchise. The new owner will invest significantly in the rooms and the exterior of the hotel and will continue to...

Quantum Genomics lists on Alternext Paris

13 Apr 2014 @ 11:56
At the unit price of €5.35 EnterNext, the Euronext subsidiary designed to promote and grow its market for SMEs, today congratulated Quantum Genomics, a biopharmaceutical research company developing new therapies for cardiovascular disease, on its transfer from the Free Market to Alternext in Paris following a €3.4 million private placement. Quantum Genomics is a biopharmaceutical company that...
  • Jump to a different page:
  • 1
  • 2
  • 3
  • ...
  • 45
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 140424 07:40